Matches in Wikidata for { <http://www.wikidata.org/entity/Q89648608> ?p ?o ?g. }
- Q89648608 description "article scientifique publié en 2017" @default.
- Q89648608 description "artículu científicu espublizáu n'avientu de 2017" @default.
- Q89648608 description "scientific article published on 15 December 2017" @default.
- Q89648608 description "wetenschappelijk artikel" @default.
- Q89648608 description "наукова стаття, опублікована в грудні 2017" @default.
- Q89648608 name "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 name "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 type Item @default.
- Q89648608 label "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 label "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 prefLabel "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 prefLabel "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic" @default.
- Q89648608 P1433 Q89648608-ADFE13A5-9BFE-4596-954B-2FA5756534C0 @default.
- Q89648608 P1476 Q89648608-62BA7339-465B-42B2-8FD1-616816DE6BC2 @default.
- Q89648608 P2093 Q89648608-02A15179-C6D6-4A40-9B84-AEAF8B24086E @default.
- Q89648608 P2093 Q89648608-234F9E01-2B24-41D4-8E43-E54BD889902D @default.
- Q89648608 P2093 Q89648608-5778B371-34ED-41E2-976D-9B108BCE5287 @default.
- Q89648608 P2093 Q89648608-622FC808-9BB2-4D89-9216-6984C41A8437 @default.
- Q89648608 P2093 Q89648608-7FCFDCA0-DC57-4CE9-9C33-598798C56AFD @default.
- Q89648608 P2093 Q89648608-839644F8-F200-4E49-A49A-7C38AAA08452 @default.
- Q89648608 P2093 Q89648608-85779ACC-53F6-48CC-849B-A6E47FBA9B81 @default.
- Q89648608 P2093 Q89648608-92E520B3-79C3-4F32-84CE-FCC927148818 @default.
- Q89648608 P2093 Q89648608-A86EA8CF-14A2-4E5F-AF2E-52D178DF7F07 @default.
- Q89648608 P2093 Q89648608-B24D8524-96BF-45C4-89C7-7B64FA90DAF3 @default.
- Q89648608 P2093 Q89648608-C5CFC069-22E7-4EE2-AFEB-38C0013EEEBE @default.
- Q89648608 P2093 Q89648608-D0729312-1D21-4C78-8AEA-B1788C4D7C4E @default.
- Q89648608 P2093 Q89648608-EEA93A0E-F26E-4AA7-9285-306380F8E3C0 @default.
- Q89648608 P2860 Q89648608-0408B9A2-0E4C-472B-A40F-7FDB72DB99B6 @default.
- Q89648608 P2860 Q89648608-060FA4C4-673A-4CE3-92A7-7F9090C8D769 @default.
- Q89648608 P2860 Q89648608-18F92FF1-D7D9-48EA-A999-91A171ED9901 @default.
- Q89648608 P2860 Q89648608-37283ACB-4D6C-454C-975D-730902EC89E8 @default.
- Q89648608 P2860 Q89648608-3A7C4A7E-0810-4827-961D-878E308031AE @default.
- Q89648608 P2860 Q89648608-3B232D9D-A668-4BA0-AD8B-951F90BB9609 @default.
- Q89648608 P2860 Q89648608-58F12AF3-F329-45D1-9760-EC4E78F2AAE0 @default.
- Q89648608 P2860 Q89648608-811E2981-9C3A-4595-8C6F-93744944869B @default.
- Q89648608 P2860 Q89648608-8A1209FB-7E27-40B2-9B62-BF9EA59F7F66 @default.
- Q89648608 P2860 Q89648608-8B0C068F-3806-45D2-AA33-D7EA46E7C1D9 @default.
- Q89648608 P2860 Q89648608-9408070A-754B-4FBD-AFF2-354F83B185B0 @default.
- Q89648608 P2860 Q89648608-956E81FE-E612-4089-A77C-242C87FEDE48 @default.
- Q89648608 P2860 Q89648608-ADC48236-56BD-42FF-8C4E-C265450CE7E0 @default.
- Q89648608 P2860 Q89648608-B36F72B3-5EB0-4D64-88A3-EA0CAD40FEBD @default.
- Q89648608 P2860 Q89648608-B39C5D3B-9723-4721-A487-6CCD40D05680 @default.
- Q89648608 P2860 Q89648608-B7AA0509-9486-44C1-A6A1-AB5757D37AE4 @default.
- Q89648608 P2860 Q89648608-BC2CB142-AA0E-4780-8432-C6BE8ED4A1F3 @default.
- Q89648608 P2860 Q89648608-BC4FCE56-BC7B-4385-93F6-59F637ECEB7E @default.
- Q89648608 P2860 Q89648608-C6D8C850-3ECA-4F12-8F8D-B22007FEE5FF @default.
- Q89648608 P2860 Q89648608-D174E08F-865F-406E-B2E6-31D136CC535F @default.
- Q89648608 P2860 Q89648608-D33D1546-820A-4398-8DE3-0BEFD1F986A8 @default.
- Q89648608 P2860 Q89648608-D8998657-BE59-446E-902F-59F9FE23A05A @default.
- Q89648608 P2860 Q89648608-D9A79B1D-2B30-49A0-8687-8363E7819A62 @default.
- Q89648608 P2860 Q89648608-DADDF9E6-FB18-4B68-ADE0-5F8E3E50949D @default.
- Q89648608 P2860 Q89648608-E0123110-4D49-4C08-AD0B-AAFAAD02BC51 @default.
- Q89648608 P2860 Q89648608-E6312126-7D37-4C01-8719-607F38F2371C @default.
- Q89648608 P2860 Q89648608-E7C19A43-2B04-4D66-BBFF-B64B6735E781 @default.
- Q89648608 P2860 Q89648608-E890D892-7BC1-4458-A8BB-FE90333957D3 @default.
- Q89648608 P2860 Q89648608-F80E7291-3AE5-4275-93C1-BBD275CD1E4D @default.
- Q89648608 P2860 Q89648608-F974C93A-3359-4D52-BD3D-31DD5CED49B3 @default.
- Q89648608 P304 Q89648608-F5F45F80-C31A-4AF2-B718-B2C9F63C0C76 @default.
- Q89648608 P31 Q89648608-ADD8BB2C-E348-4383-BA3C-8960FBC174E8 @default.
- Q89648608 P31 Q89648608-C24493E7-48C9-41DA-8989-64831FDDAF51 @default.
- Q89648608 P356 Q89648608-B82B6FD1-F38A-4EBC-A8B6-8AE2BDADE637 @default.
- Q89648608 P433 Q89648608-98212F62-3F5C-49C6-AE26-503D55814647 @default.
- Q89648608 P478 Q89648608-2C6C7906-7043-41CF-BE5D-5C507AE469B2 @default.
- Q89648608 P50 Q89648608-170F7056-083A-4443-A85E-7D8FA15EB431 @default.
- Q89648608 P50 Q89648608-7C841198-9EF1-4C1A-B145-3C0382C0E901 @default.
- Q89648608 P577 Q89648608-6000330D-A8AE-4BF3-B3F4-3E8B61291270 @default.
- Q89648608 P698 Q89648608-20BCC792-A292-43A1-9FC2-03647230EBB4 @default.
- Q89648608 P921 Q89648608-D1BF767E-1B04-4D93-AFAA-198A451D3E10 @default.
- Q89648608 P356 JCO.2017.74.7824 @default.
- Q89648608 P698 29244528 @default.
- Q89648608 P1433 Q400292 @default.
- Q89648608 P1476 "Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE" @default.
- Q89648608 P2093 "Galina Kurteva" @default.
- Q89648608 P2093 "In Hae Park" @default.
- Q89648608 P2093 "Lisa S Williams" @default.
- Q89648608 P2093 "Michael F Press" @default.
- Q89648608 P2093 "Miguel A Izquierdo" @default.
- Q89648608 P2093 "Olga Burdaeva" @default.
- Q89648608 P2093 "Roberto Hegg" @default.
- Q89648608 P2093 "Sarah Kenny" @default.
- Q89648608 P2093 "Sergei Tjulandin" @default.
- Q89648608 P2093 "Sergio D Simon" @default.
- Q89648608 P2093 "Severine Sarp" @default.
- Q89648608 P2093 "Stephen R D Johnston" @default.
- Q89648608 P2093 "William J Gradishar" @default.
- Q89648608 P2860 Q26750740 @default.
- Q89648608 P2860 Q26764863 @default.
- Q89648608 P2860 Q26785612 @default.
- Q89648608 P2860 Q27824766 @default.
- Q89648608 P2860 Q27824835 @default.
- Q89648608 P2860 Q27824846 @default.
- Q89648608 P2860 Q27851403 @default.
- Q89648608 P2860 Q27851549 @default.
- Q89648608 P2860 Q27851705 @default.
- Q89648608 P2860 Q27851917 @default.
- Q89648608 P2860 Q27853134 @default.
- Q89648608 P2860 Q27860693 @default.
- Q89648608 P2860 Q28254919 @default.
- Q89648608 P2860 Q29547699 @default.
- Q89648608 P2860 Q30665329 @default.